1-1 of 1
Ryan Hare, PharmD
Close
Sort by
Journal Articles

Dose Reductions in Ibrutinib Therapy Are Not Associated with Inferior Outcomes in Patients with Chronic Lymphocytic Leukemia (CLL)

Othman S. Akhtar, MD, Kris Attwood, PhD MS, Ian Lund, PA-C, Ryan Hare, PharmD, Francisco J. Hernandez-Ilizaliturri, MD, Pallawi Torka, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5567.
https://doi.org/10.1182/blood-2018-99-112334
Published: 2018